Get started
Daxor CorporationDaxor CorporationDaxor Corporation

Daxor Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

DXR chart


Full chart

DXR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪40.39 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
23.68
Basic EPS (TTM)
0.35 USD
Net income (FY)
‪280.64 K‬ USD
Revenue (FY)
‪34.59 M‬ USD
Shares float
‪2.02 M‬
Beta (1Y)
0.18

About Daxor Corporation


Sector
Miscellaneous
Industry
Investment Trusts/Mutual Funds
CEO
Michael R. Feldschuh
Website
daxor.com
Headquarters
Oak Ridge
Founded
1970
FIGI
BBG000BHHF34
DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

Financials


Performance
Revenue to profit conversion
Earnings
Next:—

DXR news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DXR is 7.95 USD — it has decreased by −0.60% in the past 24 hours. Watch Daxor Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Daxor Corporation stocks are traded under the ticker DXR.
DXR stock has risen by 2.34% compared to the previous week, the month change is a −10.85% fall, over the last year Daxor Corporation has showed a −0.62% decrease.
DXR reached its all-time high on Mar 14, 2000 with the price of 30.63 USD, and its all-time low was 2.13 USD and was reached on Oct 18, 1990. View more price dynamics on DXR chart.
See other stocks reaching their highest and lowest prices.
DXR stock is 4.40% volatile and has beta coefficient of 0.18. Track Daxor Corporation stock price on the chart and check out the list of the most volatile stocks — is Daxor Corporation there?
Today Daxor Corporation has the market capitalization of ‪40.15 M‬, it has increased by 2.22% over the last week.
Yes, you can track Daxor Corporation financials in yearly and quarterly reports right on TradingView.
Daxor Corporation is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
DXR net income for the last half-year is ‪−1.63 M‬ USD, while the previous report showed ‪3.32 M‬ USD of net income which accounts for −149.15% change. Track more Daxor Corporation financial stats to get the full picture.
Daxor Corporation dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Daxor Corporation EBITDA is ‪1.48 M‬ USD, and current EBITDA margin is 0.95%. See more stats in Daxor Corporation financial statements.
Like other stocks, DXR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Daxor Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Daxor Corporation technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Daxor Corporation stock shows the sell signal. See more of Daxor Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.